Common TitleStudy HAB-028: Twinrix and Long-term Persistence after Adult Immunization
Official Title An Open Single Centre Study to Evaluate the Long-term Antibody Persistence and Immune Memory Between 16 and 20 Years After the Primary Study HAB-032 (208127/022) in Which Healthy Adults Were Vaccinated With Twinrix Adult Following a Three-dose Schedule.
Phase Phase IV
ClinicalTrials.gov NCT01037114
Treatments
Twinrix
Twinrix
Tradename:TwinrixClass:Vaccines (HBV)Funding
IndustryGlaxoSmithKline